Guggenheim initiated coverage of Tenax Therapeutics with a Buy rating and $16 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TENX:
Guggenheim initiated coverage of Tenax Therapeutics with a Buy rating and $16 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TENX: